These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 37621240)

  • 61. Gut microbiota in patients after surgical treatment for colorectal cancer.
    Jin Y; Liu Y; Zhao L; Zhao F; Feng J; Li S; Chen H; Sun J; Zhu B; Geng R; Wei Y
    Environ Microbiol; 2019 Feb; 21(2):772-783. PubMed ID: 30548192
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive values of colon microbiota in the treatment response to colorectal cancer.
    Galan-Ros J; Ramos-Arenas V; Conesa-Zamora P
    Pharmacogenomics; 2020 Sep; 21(14):1045-1059. PubMed ID: 32896201
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
    Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
    Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.
    Song M; Chan AT
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):275-289. PubMed ID: 30031175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat.
    Xu R; Wang Q; Li L
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S4. PubMed ID: 26100814
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.
    Pandey H; Tang DWT; Wong SH; Lal D
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy.
    Zhang J; Wang P; Wang J; Wei X; Wang M
    Pharmacol Res; 2024 May; 203():107185. PubMed ID: 38615875
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.
    Jia W; Rajani C; Xu H; Zheng X
    Protein Cell; 2021 May; 12(5):374-393. PubMed ID: 32797354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Reasonable Diet Promotes Balance of Intestinal Microbiota: Prevention of Precolorectal Cancer.
    Huang P; Liu Y
    Biomed Res Int; 2019; 2019():3405278. PubMed ID: 31428633
    [TBL] [Abstract][Full Text] [Related]  

  • 77. It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.
    Wang X; Undi RB; Ali N; Huycke MM
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 33969420
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy.
    Yixia Y; Sripetchwandee J; Chattipakorn N; Chattipakorn SC
    Anaerobe; 2021 Apr; 68():102361. PubMed ID: 33781900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer.
    Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D
    Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.